Skip to main content
OpenTrials

Clinical trial condition

Stomach Diseases

Explore clinical trials studying Stomach Diseases. Study availability and eligibility vary by location and protocol.

2,578 public trials 586 recruiting studies
Refine in advanced search Browse all conditions

Stomach Diseases trial results

Active, Not Recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

NCT04430738

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

NCT04868877

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +24 more
Locations
  • University of California, Irvine Orange, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • START Mountain Region West Valley City, Utah, United States
  • Next Oncology Virginia Fairfax, Virginia, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

Conditions
Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

NCT04041310

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope Comprehensive Cancer Center Irvine, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Newport Beach, California, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas

NCT05583149

Conditions
Aggressive B-cell NHL, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions